Concerto Biosciences Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Concerto Biosciences is a small-to-mid-sized biotechnology company based in Cambridge, Massachusetts, focused on measuring, mapping, and harnessing the microbial world to develop therapies and consumer products. The company emphasizes outcomes powered by naturally occurring microbial symbioses to achieve real-world efficacy and durability. It operates an intelligence platform that analyzes microbial communities at scale to support a generalized AI model of microbial ecology. Its first market is skin health, with a live biotherapeutic candidate for eczema (ENS-002, Ensemble No.2) and a postbiotic ferment for consumer use (CB-002); it aims to build a pipeline across dermatology, women’s health, and food science. Recent news from April 2026 notes collaborations with the French-African Foundation and the Autonomous Advancement Initiative, involving Concerto Biosciences and Nuvision.